Tonix Pharmaceuticals stock halted ahead of FDA approval news
Core & Main Inc stock has reached an all-time high, hitting a price of 62.5 USD. This milestone marks a significant achievement for the company, reflecting a strong performance in the market. Over the past year, Core & Main Inc has experienced a notable increase in its stock value, with a 1-year change of 27.19%. This upward trajectory highlights investor confidence and the company’s positive growth outlook. As Core & Main Inc continues to expand its market presence, stakeholders are closely monitoring its performance and strategic initiatives.
In other recent news, Core & Main Inc. reported its Q1 2025 earnings, with earnings per share reaching $0.52, aligning with analyst forecasts. The company achieved a revenue of $1.9 billion, surpassing the expected $1.85 billion, marking a 10% year-over-year growth in net sales. This financial performance was accompanied by a 3% increase in adjusted EBITDA, totaling $224 million. Several analyst firms have adjusted their price targets for Core & Main. RBC Capital raised its target to $67, maintaining an Outperform rating, while Barclays (LON:BARC) increased its target to $69, citing confidence in the company’s long-term prospects and market positioning. Loop Capital also raised its price target to $68, highlighting the company’s stable outlook and steady growth driven by the Municipal segment. The company reaffirmed its full-year guidance for net sales and adjusted EBITDA, expecting a range of $950 million to $1 billion. Analysts noted that Core & Main’s performance is bolstered by municipal and infrastructure spending, along with continued gross margin improvements.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.